High prevalence of potentially hepatotoxic herbal supplement use in patients with fulminant hepatic failure

Jason D. Estes, David Stolpman, Ali Olyaei, Christopher L. Corless, John M. Ham, Jonathan M. Schwartz, Susan L. Orloff, Peter G. Stock, Lawrence A. Danto, Kaj H. Johansen, Christopher R. Shackleton, J. Craig Collins, William H. Marks, Michael Hart

Research output: Contribution to journalArticle

135 Citations (Scopus)

Abstract

Hypothesis: The use of potentially hepatotoxic herbal and dietary supplements is highly prevalent in the fulminant hepatic failure (FHF) patient population at our institution, and this subgroup of patients has a worse prognosis. Design: Retrospective case series. Settings: An adult tertiary care university hospital and a Veterans Affairs hospital in Oregon. Patients: All patients referred to the liver transplantation service for FHF from January 2001 through October 2002 (N=20). We defined FHF as onset of encephalopathy within 8 weeks of onset of jaundice in the absence of preexisting liver disease. All patients underwent investigation for potential causes of liver injury. Potentially hepatotoxic supplements were defined as those with previously published reports of hepatic injury related to their use. Results: Ten patients (50%) were recent or active users of potentially hepatotoxic supplements or herbs; 10 had no history of supplement use. In the supplement group, 7 patients (35%) had no other identified cause for hepatic failure. Six patients in the supplement group and 2 patients in the nonsupplement group underwent orthotopic liver transplantation. Five patients in each group died. There were no significant differences in transplantation rate (P=.07) or survival (P>.99) between groups. Supplement use alone accounted for the most cases of FHF during this period, exceeding acetaminophen toxicity and viral hepatitis. Conclusions: Herbal and dietary supplements were potential hepatotoxins in a high proportion of patients with FHF at our institution. Enhanced public awareness of the potential hepatotoxicity of these commonly used agents and increased regulatory oversight of their use is strongly urged.

Original languageEnglish (US)
Pages (from-to)852-858
Number of pages7
JournalArchives of Surgery
Volume138
Issue number8
DOIs
StatePublished - Aug 1 2003
Externally publishedYes

Fingerprint

Acute Liver Failure
Dietary Supplements
Liver Transplantation
Veterans Hospitals
Preexisting Condition Coverage
Liver
Liver Failure
Wounds and Injuries
Brain Diseases
Tertiary Healthcare
Acetaminophen
Jaundice
Hepatitis
Liver Diseases
Transplantation

ASJC Scopus subject areas

  • Surgery

Cite this

High prevalence of potentially hepatotoxic herbal supplement use in patients with fulminant hepatic failure. / Estes, Jason D.; Stolpman, David; Olyaei, Ali; Corless, Christopher L.; Ham, John M.; Schwartz, Jonathan M.; Orloff, Susan L.; Stock, Peter G.; Danto, Lawrence A.; Johansen, Kaj H.; Shackleton, Christopher R.; Collins, J. Craig; Marks, William H.; Hart, Michael.

In: Archives of Surgery, Vol. 138, No. 8, 01.08.2003, p. 852-858.

Research output: Contribution to journalArticle

Estes, JD, Stolpman, D, Olyaei, A, Corless, CL, Ham, JM, Schwartz, JM, Orloff, SL, Stock, PG, Danto, LA, Johansen, KH, Shackleton, CR, Collins, JC, Marks, WH & Hart, M 2003, 'High prevalence of potentially hepatotoxic herbal supplement use in patients with fulminant hepatic failure', Archives of Surgery, vol. 138, no. 8, pp. 852-858. https://doi.org/10.1001/archsurg.138.8.852
Estes, Jason D. ; Stolpman, David ; Olyaei, Ali ; Corless, Christopher L. ; Ham, John M. ; Schwartz, Jonathan M. ; Orloff, Susan L. ; Stock, Peter G. ; Danto, Lawrence A. ; Johansen, Kaj H. ; Shackleton, Christopher R. ; Collins, J. Craig ; Marks, William H. ; Hart, Michael. / High prevalence of potentially hepatotoxic herbal supplement use in patients with fulminant hepatic failure. In: Archives of Surgery. 2003 ; Vol. 138, No. 8. pp. 852-858.
@article{06ba30aa472a4ede9b4cf3aa92b62c3c,
title = "High prevalence of potentially hepatotoxic herbal supplement use in patients with fulminant hepatic failure",
abstract = "Hypothesis: The use of potentially hepatotoxic herbal and dietary supplements is highly prevalent in the fulminant hepatic failure (FHF) patient population at our institution, and this subgroup of patients has a worse prognosis. Design: Retrospective case series. Settings: An adult tertiary care university hospital and a Veterans Affairs hospital in Oregon. Patients: All patients referred to the liver transplantation service for FHF from January 2001 through October 2002 (N=20). We defined FHF as onset of encephalopathy within 8 weeks of onset of jaundice in the absence of preexisting liver disease. All patients underwent investigation for potential causes of liver injury. Potentially hepatotoxic supplements were defined as those with previously published reports of hepatic injury related to their use. Results: Ten patients (50{\%}) were recent or active users of potentially hepatotoxic supplements or herbs; 10 had no history of supplement use. In the supplement group, 7 patients (35{\%}) had no other identified cause for hepatic failure. Six patients in the supplement group and 2 patients in the nonsupplement group underwent orthotopic liver transplantation. Five patients in each group died. There were no significant differences in transplantation rate (P=.07) or survival (P>.99) between groups. Supplement use alone accounted for the most cases of FHF during this period, exceeding acetaminophen toxicity and viral hepatitis. Conclusions: Herbal and dietary supplements were potential hepatotoxins in a high proportion of patients with FHF at our institution. Enhanced public awareness of the potential hepatotoxicity of these commonly used agents and increased regulatory oversight of their use is strongly urged.",
author = "Estes, {Jason D.} and David Stolpman and Ali Olyaei and Corless, {Christopher L.} and Ham, {John M.} and Schwartz, {Jonathan M.} and Orloff, {Susan L.} and Stock, {Peter G.} and Danto, {Lawrence A.} and Johansen, {Kaj H.} and Shackleton, {Christopher R.} and Collins, {J. Craig} and Marks, {William H.} and Michael Hart",
year = "2003",
month = "8",
day = "1",
doi = "10.1001/archsurg.138.8.852",
language = "English (US)",
volume = "138",
pages = "852--858",
journal = "JAMA Surgery",
issn = "2168-6254",
publisher = "American Medical Association",
number = "8",

}

TY - JOUR

T1 - High prevalence of potentially hepatotoxic herbal supplement use in patients with fulminant hepatic failure

AU - Estes, Jason D.

AU - Stolpman, David

AU - Olyaei, Ali

AU - Corless, Christopher L.

AU - Ham, John M.

AU - Schwartz, Jonathan M.

AU - Orloff, Susan L.

AU - Stock, Peter G.

AU - Danto, Lawrence A.

AU - Johansen, Kaj H.

AU - Shackleton, Christopher R.

AU - Collins, J. Craig

AU - Marks, William H.

AU - Hart, Michael

PY - 2003/8/1

Y1 - 2003/8/1

N2 - Hypothesis: The use of potentially hepatotoxic herbal and dietary supplements is highly prevalent in the fulminant hepatic failure (FHF) patient population at our institution, and this subgroup of patients has a worse prognosis. Design: Retrospective case series. Settings: An adult tertiary care university hospital and a Veterans Affairs hospital in Oregon. Patients: All patients referred to the liver transplantation service for FHF from January 2001 through October 2002 (N=20). We defined FHF as onset of encephalopathy within 8 weeks of onset of jaundice in the absence of preexisting liver disease. All patients underwent investigation for potential causes of liver injury. Potentially hepatotoxic supplements were defined as those with previously published reports of hepatic injury related to their use. Results: Ten patients (50%) were recent or active users of potentially hepatotoxic supplements or herbs; 10 had no history of supplement use. In the supplement group, 7 patients (35%) had no other identified cause for hepatic failure. Six patients in the supplement group and 2 patients in the nonsupplement group underwent orthotopic liver transplantation. Five patients in each group died. There were no significant differences in transplantation rate (P=.07) or survival (P>.99) between groups. Supplement use alone accounted for the most cases of FHF during this period, exceeding acetaminophen toxicity and viral hepatitis. Conclusions: Herbal and dietary supplements were potential hepatotoxins in a high proportion of patients with FHF at our institution. Enhanced public awareness of the potential hepatotoxicity of these commonly used agents and increased regulatory oversight of their use is strongly urged.

AB - Hypothesis: The use of potentially hepatotoxic herbal and dietary supplements is highly prevalent in the fulminant hepatic failure (FHF) patient population at our institution, and this subgroup of patients has a worse prognosis. Design: Retrospective case series. Settings: An adult tertiary care university hospital and a Veterans Affairs hospital in Oregon. Patients: All patients referred to the liver transplantation service for FHF from January 2001 through October 2002 (N=20). We defined FHF as onset of encephalopathy within 8 weeks of onset of jaundice in the absence of preexisting liver disease. All patients underwent investigation for potential causes of liver injury. Potentially hepatotoxic supplements were defined as those with previously published reports of hepatic injury related to their use. Results: Ten patients (50%) were recent or active users of potentially hepatotoxic supplements or herbs; 10 had no history of supplement use. In the supplement group, 7 patients (35%) had no other identified cause for hepatic failure. Six patients in the supplement group and 2 patients in the nonsupplement group underwent orthotopic liver transplantation. Five patients in each group died. There were no significant differences in transplantation rate (P=.07) or survival (P>.99) between groups. Supplement use alone accounted for the most cases of FHF during this period, exceeding acetaminophen toxicity and viral hepatitis. Conclusions: Herbal and dietary supplements were potential hepatotoxins in a high proportion of patients with FHF at our institution. Enhanced public awareness of the potential hepatotoxicity of these commonly used agents and increased regulatory oversight of their use is strongly urged.

UR - http://www.scopus.com/inward/record.url?scp=0041530157&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0041530157&partnerID=8YFLogxK

U2 - 10.1001/archsurg.138.8.852

DO - 10.1001/archsurg.138.8.852

M3 - Article

VL - 138

SP - 852

EP - 858

JO - JAMA Surgery

JF - JAMA Surgery

SN - 2168-6254

IS - 8

ER -